Squarepoint’s Pacira BioSciences PCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$512K Buy
+21,407
New +$512K ﹤0.01% 1899
2025
Q1
Sell
-60,836
Closed -$1.15M 3108
2024
Q4
$1.15M Buy
60,836
+25,505
+72% +$481K ﹤0.01% 1447
2024
Q3
$532K Buy
35,331
+6,823
+24% +$103K ﹤0.01% 1718
2024
Q2
$816K Buy
28,508
+6,794
+31% +$194K ﹤0.01% 1472
2024
Q1
$634K Buy
+21,714
New +$634K ﹤0.01% 1550
2023
Q3
Sell
-20,715
Closed -$830K 2746
2023
Q2
$830K Buy
+20,715
New +$830K ﹤0.01% 1362
2023
Q1
Sell
-13,252
Closed -$512K 2643
2022
Q4
$512K Buy
13,252
+86
+0.7% +$3.32K ﹤0.01% 1448
2022
Q3
$700K Sell
13,166
-1,377
-9% -$73.2K ﹤0.01% 1245
2022
Q2
$848K Sell
14,543
-26,663
-65% -$1.55M ﹤0.01% 1122
2022
Q1
$3.15M Sell
41,206
-4,886
-11% -$373K 0.01% 617
2021
Q4
$2.77M Sell
46,092
-13,327
-22% -$802K 0.01% 716
2021
Q3
$3.33M Buy
59,419
+25,064
+73% +$1.4M 0.01% 609
2021
Q2
$2.09M Buy
+34,355
New +$2.09M 0.01% 785
2021
Q1
Sell
-15,336
Closed -$918K 2930
2020
Q4
$918K Sell
15,336
-10,985
-42% -$658K 0.01% 1142
2020
Q3
$1.58M Buy
26,321
+16,906
+180% +$1.02M 0.02% 725
2020
Q2
$494K Buy
+9,415
New +$494K 0.01% 1310
2020
Q1
Sell
-39,656
Closed -$1.8M 2295
2019
Q4
$1.8M Buy
39,656
+7,751
+24% +$351K 0.01% 946
2019
Q3
$1.22M Sell
31,905
-2,835
-8% -$108K 0.01% 1069
2019
Q2
$1.51M Sell
34,740
-81,810
-70% -$3.56M 0.01% 992
2019
Q1
$4.44M Buy
116,550
+81,822
+236% +$3.11M 0.05% 480
2018
Q4
$1.49M Buy
34,728
+12,450
+56% +$536K 0.02% 765
2018
Q3
$1.1M Buy
22,278
+11,289
+103% +$555K 0.01% 949
2018
Q2
$352K Buy
+10,989
New +$352K ﹤0.01% 1322
2018
Q1
Sell
-10,680
Closed -$488K 2016
2017
Q4
$488K Buy
+10,680
New +$488K 0.01% 1217
2016
Q4
Sell
-28,592
Closed -$978K 1887
2016
Q3
$978K Buy
+28,592
New +$978K 0.06% 359
2015
Q4
Sell
-13,100
Closed -$538K 1292
2015
Q3
$538K Buy
+13,100
New +$538K 0.13% 187